NCT04332978
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
- Locations
-
Not specified
Clinical trial condition
Perennial Allergic Rhinitis
Explore clinical trials studying Perennial Allergic Rhinitis. Study availability and eligibility vary by location and protocol.
64 public trials
2 recruiting studies
Perennial Allergic Rhinitis trial results
NCT04324918
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
- Locations
-
- Gangnam Severance Hospital. Seoul, South Korea
NCT02709538
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
- Locations
-
- Investigational Site 2 Hot Springs, Arkansas, United States
- Investigational Site 28 Encinitas, California, United States
- Investigational Site 27 San Diego, California, United States
- Investigational Site 29 San Diego, California, United States
NCT03127436
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
- Locations
-
- Praxis für Lungenheilkunde Vienna, Austria
Completed
To Evaluate the Efficacy and Safety of HL151 Versus Placebo in Perennial Allergic Rhinitis Patients
NCT03655210
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
- Locations
-
- Seoul National University Hospital Gyeonggi-do, South Korea
NCT01982916
- Conditions
- Allergic Rhinitis, Hypersensitivity, Hypersensitivity, Immediate, +10 more
- Locations
-
- Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-do, South Korea
- Inha University Hospital Incheon, South Korea
- Seoul National University Hospital Seoul, South Korea
- Severance Hospital Seoul, South Korea
NCT02532179
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +12 more
- Locations
-
- Children's National Health System Washington D.C., District of Columbia, United States
- Ann and Robert Lurie Children's Hospital of Chicago Chicago, Illinois, United States
- Johns Hopkins Children's Center: Department of Allergy & Immunology Baltimore, Maryland, United States
- Henry Ford Health System: Division of Allergy and Immunology Detroit, Michigan, United States
NCT00789555
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +9 more
- Locations
-
- Contact Alcon Call Center For Trial Locations Fort Worth, Texas, United States
Completed
Safety Study of Olopatadine Nasal Spray
NCT00578331
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +10 more
- Locations
-
- Waco Waco, Texas, United States
NCT00730912
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
- Locations
-
Not specified